Richard Buchholz Joins Presidio Medical’s Board of Directors

Presidio Medical Inc. has appointed Richard J. Buchholz to its Board of Directors.

“We are excited that Rick is joining the Board of Directors of Presidio Medical at this critical time in our company’s journey,” Presidio Medical Chairman/CEO Michael Onuscheck said. “His leadership and financial acumen will be instrumental in advancing our vision through key growth and development stages.”

Buchholz has been chief financial officer (CFO) of Inspire Medical Systems Inc. since 2014. He has played a pivotal role in driving strategic financial and operational growth in developing and commercializing minimally invasive solutions for patients with obstructive sleep apnea.

Before he began working at Inspire, Buchholz was CFO at superDimension Ltd. from 2006 through its acquisition by Covidien plc in 2013. Buchholz also served as CFO of Vascular Solutions Inc., which was acquired by Teleflex Incorporated.

Buchholz earned a B.B.A. from the University of Wisconsin, Eau Claire, and is a certified public accountant (inactive).

“I am excited to join the board as an independent director and work with the entire team through the next phases of the company’s development,” Buchholz stated. “Presidio Medical’s vision of revolutionizing the way neuromodulation balances the human nervous system—enabling people to live their best life, aligns with my passion for bringing innovative technologies to market that could profoundly impact patient care.”

Founded in 2017, Presidio Medical is headquartered in San Mateo, Calif. The clinical stage, privately held medical device company is developing a transformational neuromodulation platform to treat diseases of undesired neural activity with a first indication in treating chronic pain. Presidio’s investors include Deerfield Management, Invus Opportunities, Action Potential Venture Capital, and ShangBay Capital.